ASX:ANR Anatara Lifesciences (ANR) Stock Price, News & Analysis → The #1 lithium battery stock to have on your radar in 2024! (From Smallcaps Daily) (Ad) Free ANR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3,950 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Anatara Lifesciences alerts: Email Address Ad Smallcaps DailyThe #1 lithium battery stock to have on your radar in 2024!Discover Why Zacks Small Cap Research Issued a “STRONG BUY” Rating on this Little-Known NASDAQ-traded Green Energy Company!Learn More Here About Anatara LifesciencesAnatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry in water. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.Read More Ad Smallcaps DailyThe #1 lithium battery stock to have on your radar in 2024!Discover Why Zacks Small Cap Research Issued a “STRONG BUY” Rating on this Little-Known NASDAQ-traded Green Energy Company!Learn More Here ANR Stock News HeadlinesJanuary 23, 2024 | forbes.comEdwards LifesciencesOctober 5, 2023 | wsj.comEris Lifesciences Ltd.May 7, 2024 | Preserve Gold (Ad)Trump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Christine Lagarde, President of the European Central Bank, shared "Now we have in Europe this threshold, above 1,000 euros you cannot pay cash… if you get caught you are fined or you are going to jail". Are you prepared?August 9, 2023 | finance.yahoo.comEdwards Lifesciences (EW) Q2 Earnings Top Estimates, View UpJune 16, 2023 | wsj.comMega Lifesciences PCLMay 10, 2023 | wsj.comZydus Lifesciences Ltd.April 4, 2023 | proactiveinvestors.com.auInnovation begins with collaboration: Steven LydeamoreMarch 29, 2023 | finance.yahoo.comAnatara Lifesciences Ltd (ANR.AX)May 7, 2024 | Preserve Gold (Ad)Trump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Christine Lagarde, President of the European Central Bank, shared "Now we have in Europe this threshold, above 1,000 euros you cannot pay cash… if you get caught you are fined or you are going to jail". Are you prepared?March 11, 2023 | benzinga.comEdwards Lifesciences Stock (NYSE:EW), DividendsSeptember 21, 2022 | reuters.comAnatara Lifesciences LtdSeptember 7, 2021 | investing.comAnatara Lifesciences Ltd (ANR)September 6, 2021 | sg.finance.yahoo.comAnatara Lifesciences Limited (ANR.AX) Meet the CEO Investor WebinarSeptember 6, 2021 | uk.finance.yahoo.comAnatara Lifesciences Limited (ANR.AX) Investor PresentationAugust 20, 2021 | au.finance.yahoo.comAnatara Lifesciences Limited (ANR.AX) Launches IBS-D Clinical Trial Recruitment WebsiteAugust 6, 2021 | au.finance.yahoo.comAnatara Lifesciences Limited (ANR.AX) Successful Piglet StudyJuly 28, 2021 | uk.finance.yahoo.comAnatara Lifesciences Limited (ANR.AX) Monthly Activities ReportSee More Headlines Receive ANR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Anatara Lifesciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:ANR CUSIPN/A CIKN/A Webwww.anataralifesciences.com Phone61 7 3394 8202FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,750,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-117.14% Return on Assets-65.37% Debt Debt-to-Equity Ratio3.24 Current Ratio8.90 Quick Ratio4.69 Sales & Book Value Annual Sales$1.25 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.33 Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares167,890,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.65 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. David Lionel Brookes F.A.C.I.D. (Age 64)FACRRM, FAICD, MBBS, Executive Chairman Comp: $168.21kMr. John Michailidis B.Sc.EMBA, M.A.I.C.D., COO & Executive DirectorMr. Simon ErskineChief Development OfficerJane LoweManaging Director of IR DepartmentDr. Stephen Denaro AGIABCom, CA, GradDipApp CG, MAICD, Company SecretaryMs. Hayley van der Meer B Biomed ScGrad Dip Marketing Management, Commercial ManagerMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersJohn MichailidisSold 250,000 sharesTotal: $5,500.00 ($0.02/share)David BrookesSold 725,716 sharesTotal: $15,965.75 ($0.02/share) ANR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Anatara Lifesciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Anatara Lifesciences investors own include Woodside Petroleum (WPL), Temple & Webster Group (TPW), Brompton Oil Split (OSP), Eagle Materials (EXP), BHP Group (BHP) and Ameriprise Financial (AMP). This page (ASX:ANR) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupTrump is sounding the alarmPreserve GoldBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversBirch GoldIs Tesla going out of business?DTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anatara Lifesciences Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
